José Carlos Villa Guzmán
José Carlos Villa Guzmán
MEDICAL ONCOLOGY SPECIALIST
See more specialists on
Ciudad Realciudadreal
en/medical-staff/oncologist
Dr. José Carlos Villa Guzmán is a leading medical oncologist currently practicing at the Hospital Quirón salud . His academic background includes a degree in Medicine and Surgery from the Universidad de Granada, obtained in 2003, and a specialization in medical oncology at the Hospital Universitario Reina Sofía in Córdoba in 2009. Among his scientific contributions, his publication in "Lancet Oncol." stands out. Titled "Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial," it was published in May 2017. Furthermore, Dr. Villa Guzmán is a member of the Spanish Genitourinary Oncology Group, reflecting his commitment to research and advancements in cancer treatment.
Key information
- Latest Publication:Current Trends in the Chemotherapy of Colorectal Cancer.
- Belongs to:Hospital General Universitario Ciudad Real
Professional Details
Hospital Quirónsalud Ciudad Real
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
October 2020
HOSPITAL GENERAL UNIVERSITARIO CIUDAD REAL
OPTIONAL
January 2009
Study
BACHELOR OF MEDICINE AND SURGERY
university, UNIV. GRANADA
2003
Doctorate
UNIVERSIDAD CORDOBA
2011
Specialized Healthcare Training
SPECIALTY: MEDICAL ONCOLOGY
hospital
Another qualification
RESEARCH PROFICIENCY
university
Multidisciplinary management of renal cancer
grupo de trabajo ONCOSUR
June 2017
Supervision of final degree projects in medicine
Universidad de Castilla-La Mancha
April 2017
INTEGRATING ADVANCES IN MOLECULAR DIAGNOSIS AND TREATMENT WITH TYROSINE KINASE INHIBITORS, IMMUNODRUGS AND SBRT IN PATIENTS CARRYING DRIVER MUTATIONS.
Unidad de Investigación, Docencia, Formación, Calidad y Biblioteca
June 2016
III COURSE ON THE MANAGEMENT OF GENITOURINARY TUMORS
Unidad de Investigación, Docencia, Formación, Calidad y Biblioteca
May 2016
Supervision of final degree projects in medicine
Universidad de Castilla-La Mancha
April 2016
III CONFERENCE ON THE MANAGEMENT OF LUNG CANCER: LET'S ALL TALK
Unidad de Investigación, Docencia, Formación y Calidad
March 2015
III Lung Cancer Course of the Sociedad Castellano Manchega de Oncología Médica
Sociedad Castellano Manchega de Oncología Médica
October 2014
General Session: Immunotherapy in lung cancer
Unidad de Investigación, Docencia, Formación y Calidad del Hospital General Universitario de Ciudad Real
September 2014
Multidisciplinary session on the approach to laryngeal cancer
Unidad de Investigación, Docencia, Formación y Calidad del Hospital General Universitario de Ciudad Real
June 2014
2nd Comprehensive Conference on the Management of Patients with Prostate Cancer
Unidad de Investigación, Docencia, Formación y Calidad del Hospital General Universitario de Ciudad Real
March 2014
1st Comprehensive Conference on the Management of Patients with Prostate Cancer
Unidad de Investigación, Docencia, Formación y Calidad del Hospital General Universitario de Ciudad Real
March 2013
VIII SEOM TRAINING COURSE IN CONTINUOUS CARE
Sociedad Española de Oncología Médica
December 2011
1st COMPREHENSIVE MEDICAL ONCOLOGY CONFERENCE ON BREAST AND KIDNEY CANCER
Unidad de Investigación, Docencia, Formación y Calidad del Hospital General Universitario de Ciudad Real
December 2010
Basic Clinical Oncology Course
Unidad de Investigación, Docencia, Formación y Calidad del Hospital General Universitario de Ciudad Real
May 2010
Prospective multicenter study of prognostic factors in castration-resistant prostate cancer treated with DoceTAxel
REASSURE-Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC population for long-term Evaluation
Prospective multicenter study of prognostic factors in castration-resistant prostate cancer treated with enzalutamide
Mutational dynamics in patients with advanced non-small cell lung cancer with EGFR mutation in first-line treatment
Prognostic value of mediastinal restaging by ultrasound-guided bronchoscopy (EBUS) in patients with unresectable stage III non-small cell lung carcinoma treated with concomitant chemo-radiotherapy (CT-RT)
Prospective multicenter study of prognostic factors in castration-resistant prostate cancer treated with Radium 223
Observational, prospective, multicenter study of quality of life in relation to fatigue and hand-foot syndrome in patients with metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor in first line (TROYA Study)
Prospective multicenter study of prognostic factors in castration-resistant prostate cancer treated with abiraterone
Current Trends in the Chemotherapy of Colorectal Cancer.
Scientific article
Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms.
Scientific article
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
Scientific article
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Scientific article
Quantitation of sunitinib, an oral multi-target tyrosine kinase inhibitor, and its metabolite in urine samples by non-aqueous capillary electrophoresis time of flight mass spectrometry.
Scientific article
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor.
Scientific article
Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
Scientific article
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.
Scientific article
Simultaneous determination of erlotinib and metabolites in human urine using capillary electrophoresis.
Scientific article
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.
Scientific article
Hospital General Universitario Ciudad Real
Revista Científica Apuntes de Ciencia
Grupo Español de Cáncer de Pulmón
Grupo Español de Tumores Digestivos
Comisión de Farmacia del Hospital General Universitario de Ciudad Real
Grupo Español de Oncología Genitourinaria
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Hospital Quirónsalud Ciudad Real
C/ Alisos, 19
13002 Ciudad Real
Articles on
Browse the latest articles on Tu canal de salud.
¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.